| Laps de temps | Prix prévu | Passé | Historique | Aperçu |
|---|---|---|---|---|
| Demain | $35.93 ▼ -0.97% | Hier | $36.43 ▲ +0.41% | Tomorrow's TG Therapeutics Inc. Common Stock (TGTX) setup is anchored to $36.28 and targets $35.93 (-0.97%). The near-term read is downside; watch $37.37 / $35.19 because daily realized volatility is about 5.01%. |
Tomorrow's TG Therapeutics Inc. Common Stock (TGTX) setup is anchored to $36.28 and targets $35.93 (-0.97%). The near-term read is downside; watch $37.37 / $35.19 because daily realized volatility is about 5.01%. | ||||
| Semaine | $35.18 ▼ -3.02% | La semaine dernière | $36.74 ▲ +1.27% | The 7-day TG Therapeutics Inc. Common Stock model moves from $36.74 to $35.18 (-3.02%). It gives downside momentum context for this stock, so breaks around $37.37 / $35.19 matter more than a single tick. |
The 7-day TG Therapeutics Inc. Common Stock model moves from $36.74 to $35.18 (-3.02%). It gives downside momentum context for this stock, so breaks around $37.37 / $35.19 matter more than a single tick. | ||||
| Mois | $33.94 ▼ -6.44% | Mois dernier | $37.26 ▲ +2.71% | The 1-month TG Therapeutics Inc. Common Stock target is $33.94 (-6.44%), compared with the live reference near $36.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month TG Therapeutics Inc. Common Stock target is $33.94 (-6.44%), compared with the live reference near $36.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Année | $32.08 ▼ -11.57% | L'année dernière | $38.04 ▲ +4.86% | The 1-year TG Therapeutics Inc. Common Stock scenario points to $32.08 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year TG Therapeutics Inc. Common Stock scenario points to $32.08 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 ans | $27.73 ▼ -23.57% | Il y a 5 ans | $39.87 ▲ +9.90% | The 5-year TG Therapeutics Inc. Common Stock view is $27.73 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year TG Therapeutics Inc. Common Stock view is $27.73 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicateur | Valeur | Signal |
|---|---|---|
| Price | $36.28 | Mid |
| Daily Change | -1.84% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 61% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $36.28 | Daily Change | -1.84% |
| Market Cap | $5.79B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.